News
February 21, 2019 Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies
Read More
December 27, 2018 Boston Scientific Exercises Option to Acquire Millipede, Inc. for $540M (Santé Ventures Leads Deal as Only Institutional Investor)
Read More